Alcon Inc. Overview
Pro stress-test →Alcon is the global leader in eye care with a heritage spanning over 75 years, offering the broadest portfolio of products to enhance sight and improve people's lives. The company grew 2025 sales to $10.3B, serving medical professionals and patients across surgical and vision care segments.
Strategic Profile
Pro stress-test →Alcon develops and markets surgical equipment and devices, pharmaceutical eye drops, and consumer vision care products through Surgical and Vision Care segments, with the Surgical segment offering implantable products, consumables and equipment for cataracts, vitreoretinal conditions, refractive errors, and glaucoma, while the Vision Care segment comprises contact lenses and ocular health products. The company successfully launched a wave of innovative new products that fueled sales acceleration in 2025.
Competitive Landscape
Pro stress-test →Alcon, headquartered in Geneva, Switzerland, is a global leader in eye care that spun off from Novartis in 2019 to operate independently. The company competes in large fragmented markets for surgical eye care equipment and contact lenses against diversified healthcare conglomerates and specialized ophthalmology players. Market leadership is driven by breadth of product portfolio, innovation velocity, and global distribution reach.
Industry Context
Alcon Inc. operates in Medical Devices - Ophthalmology.
Key facts
Founded: 1945 · Headquarters: Geneva, Switzerland · Employees: 25,940 · Revenue: $10.3B · Market cap: $32.6B